(with Stanford University School of Medicine and Charité University Medicine, Berlin, Germany)
Jan Pietzsch
Jan Pietzsch's research interests are in probabilistic systems analysis and innovation management. A particular focus of his work is the assessment and evaluation of new technologies. The emphasis of this work is on providing decision support for industry and investors during research, design, development, and early testing, where evidence is still limited. A primary application field is medical technology, where early understanding of the health-economic profile and value proposition of emerging technologies is increasingly becoming a critical element of successful product commercialization.
Dr. Pietzsch is President and CEO of Wing Tech Inc., a management consulting firm active in the fields of technology assessment, advanced systems analysis, and strategic decision support. In addition to his appointment as Consulting Associate Professor in the Department of Management Science and Engineering, he also serves as a Core Faculty member in the Stanford Biodesign Program.
For list of publications and invited talks, please go to: http://www.stanford.edu/group/ERRG/jan1.htm.
Last modified Wed, 25 Jul, 2012 at 10:55
Health-economic Studies in Regenerative Cell Therapy – Early-stage decision support for focused product development
Value and Impact of Medical Technology in the Treatment of Chronic Wounds
(with Northwestern University)
A Comprehensive Analysis of the FDA 510(k) Process: Industry Practice and Implications for Reform
(with Northwestern University)
Assessing the Impact of Medical Technology in the Diagnosis and Treatment of Obstructive Sleep Apnea
(with Northwestern University)
